-- 週四午盤前後，北極星（Polaris，股票代號：PII）股價上漲約14%，此前該公司表示，預計近期關稅政策的變化（不包括潛在的退稅）不會對其3月發布的2026年業績展望產生重大影響。 該公司表示，其在美國國內擁有「相當可觀」的生產能力，工廠位於阿拉巴馬州、印第安納州和明尼蘇達州。 今年1月，北極星曾發布2026年調整後每股盈餘預期為1.50美元至1.60美元；3月3日，該公司將調整後每股盈餘預期上調至1.60美元至1.70美元。
Price: $54.92, Change: $+7.04, Percent Change: +14.69%
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.